Compare EHang Holdings Ltd - ADR (EH) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs IDEXX Laboratories, Inc. — how do they compare? EHang Holdings Ltd - ADR trades at $4.17 (market cap $309.45M), while IDEXX Laboratories, Inc. trades at $518.89 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 130.7× EHang Holdings Ltd - ADR's market cap, and EHang Holdings Ltd - ADR is more actively traded (765,799 versus 692,164). Which is the better fit depends on your goals — on Pluang, investors hold EHang Holdings Ltd - ADR for 47 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| EH | IDXX | |
|---|---|---|
Market Cap | $309.45M | $40.43B |
Volume | 765,799 | 692,164 |
Sector | Industrials | Health |
52-Week High | $18.94 | $766.68 |
52-Week Low | $4.03 | $504.70 |
Typical Hold Time | 47 Days | 46 Days |
Enterprise Value | $261.14M | $41.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EHang Holdings Limited (EH) trades at $4.14, showing no recent price movement. The stock is technically bearish with moving averages signaling a downtrend. Fundamentally, the company reported a net loss of $275.98 million on $417.98 million revenue in 2025, with negative profit margins and returns. Recent news includes expansion of its Global Fast Track Program to Vietnam but also multiple law firm investigations into investor claims.
The outlook remains challenging with persistent losses and regulatory scrutiny. Investment opportunities hinge on successful commercialization of eVTOL technology, but risks include high cash burn, negative earnings, and legal uncertainties. Analyst consensus is mixed with 20% buy, 40% hold, and 40% sell ratings, reflecting cautious sentiment.
IDEXX Laboratories (IDXX) trades at $519.87, up 2.61% on the day, with a bearish technical signal from moving averages but strong fundamentals including a 25.03% net income margin and consistent earnings beats. Revenue grew to $4.3B in 2025, and the company recently acquired CoVetAI to enhance veterinary workflow intelligence, signaling strategic expansion.
The stock's outlook is supported by robust profitability and analyst consensus, but faces headwinds from technical weakness and potential market volatility. With a $665 price target implying significant upside, the primary risks include competitive pressures and execution of growth initiatives amid economic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
